Resultados globales: 3 registros encontrados en 0.03 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
14 p, 1.9 MB Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate : An Interrupted Time Series Study / Abtahi, Shahab (Utrecht University) ; Pajouheshnia, Romin (Utrecht University) ; Durán, Carlos E. (University Medical Center Utrecht) ; Riera-Arnau, Judit (Hospital Universitari Vall d'Hebron) ; Gamba, Magdalena (Utrecht University) ; Alsina, Ema (University Medical Center Utrecht) ; Hoxhaj, Vjola (University Medical Center Utrecht) ; Andersen, Morten (University of Copenhagen. Department of Drug Design and Pharmacology) ; Bartolini, Claudia (Agenzia Regionale di Sanità della Toscana) ; Kristiansen, Sarah Brøgger (University of Copenhagen. Department of Drug Design and Pharmacology) ; Brown, Jeremy (London School of Hygiene & Tropical Medicine) ; Hallgreen, Christine Erikstrup (University of Copenhagen. Copenhagen Centre for Regulatory Science) ; Garcia-Poza, Patricia (Agencia Espanola de Medicamentos y Productos Sanitarios) ; Gardarsdottir, Helga (UMCU. Department of Clinical Pharmacy) ; Gini, Rosa (Agenzia Regionale di Sanità della Toscana) ; Girardi, Anna (Agenzia Regionale di Sanità della Toscana) ; Holthuis, Emily (PHARMO Institute for Drug Outcomes Research) ; Huerta, Consuelo (Universidad Complutense de Madrid. Departamento de Salud Pública y Materno-Infantil) ; Ibáñez, Luisa (Hospital Universitari Vall d'Hebron) ; Limoncella, Giorgio (Agenzia Regionale di Sanità della Toscana) ; Martín-Pérez, Mar (Agencia Espanola de Medicamentos y Productos Sanitarios) ; Paoletti, Olga (Agenzia Regionale di Sanità della Toscana) ; Roberto, Giuseppe (Agenzia Regionale di Sanità della Toscana) ; Souverein, Patrick (Utrecht University) ; Swart, Karin M. A. (PHARMO Institute for Drug Outcomes Research) ; Wing, Kevin (London School of Hygiene & Tropical Medicine) ; Sturkenboom, Miriam (University Medical Center Utrecht) ; Klungel, Olaf (Utrecht University) ; Universitat Autònoma de Barcelona
Due to established teratogenicity of valproates, the EU risk minimisation measures (RMMs) with a pregnancy prevention programme (PPP) for valproate were updated in March 2018. To investigate the effectiveness of the 2018 EU RMMs on valproate utilisation in five European countries/regions. [...]
2023 - 10.1007/s40264-023-01314-3
Drug Safety, june 2023, p. 1-14  
2.
7 p, 710.9 KB Indications related to antidepressant prescribing in the Nivel-PCD database and the SIDIAP database / Camacho-Arteaga, Lina (Hospital Universitari Vall d'Hebron) ; Gardarsdottir, Helga (Utrecht University. Division of Pharmacoepidemiology and Clinical Pharmacology) ; Ibáñez, Luisa (Hospital Universitari Vall d'Hebron) ; Souverein, Patrick (Utrecht University. Division of Pharmacoepidemiology and Clinical Pharmacology) ; van Dijk, Liset (Netherlands Institute for Health Services Research (NIVEL)) ; Hek, Karin (Netherlands Institute for Health Services Research (NIVEL)) ; Vidal Guitart, Xavier (Hospital Universitari Vall d'Hebron) ; Ballarín, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sabaté, Mònica (Hospital Universitari Vall d'Hebron)
Antidepressant drug consumption has increased, mainly in the elderly. This trend could be explained by the use for indications other than depression. We aimed to describe the indications related to antidepressant drug new users in two primary care settings.
2022 - 10.1016/j.jad.2022.02.001
Journal of affective disorders, Vol. 303 (04 2022) , p. 131  
3.
16 p, 1.2 MB Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015) : A cross-national drug utilization study / Ibáñez, Luisa (Universitat Autònoma de Barcelona) ; Sabaté, Mònica (Universitat Autònoma de Barcelona) ; Vidal Guitart, Xavier (Universitat Autònoma de Barcelona) ; Ballarín, Elena (Hospital Universitari Vall d'Hebron) ; Rottenkolber, Marietta (Klinikum der Universität München) ; Schmiedl, Sven (Helios University Hospital Wuppertal) ; Heeke, Andreas (AOK NORDWEST) ; Huerta, Consuelo (Agencia Española de Medicamentos y Productos Sanitarios) ; Martin Merino, Elisa (Agencia Española de Medicamentos y Productos Sanitarios) ; Montero, Dolores (Agencia Española de Medicamentos y Productos Sanitarios) ; Leon-Muñoz, Luz María (Agencia Española de Medicamentos y Productos Sanitarios) ; Gasse, Christiane (Aarhus University) ; Moore, Nicholas (INSERM CIC1401, Université de Bordeaux) ; Droz, Cécile (INSERM CIC1401, Université de Bordeaux) ; Lassalle, Régis (INSERM CIC1401, Université de Bordeaux) ; Aakjær, Mia (University of Copenhagen) ; Andersen, Morten (University of Copenhagen) ; De Bruin, Marie Louise (University of Copenhagen) ; Groenwold, Rolf (Leiden University Medical Center) ; van den Ham, Hendrika A. (Universiteit Utrecht, David de Wiedgebouw) ; Souverein, Patrick (Universiteit Utrecht, David de Wiedgebouw) ; Klungel, Olaf (University Medical Center Utrecht) ; Gardarsdottir, Helga (University of Iceland) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron
To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 European healthcare databases representing 6 European countries. [...]
2019 - 10.1111/bcp.14071
British Journal of Clinical Pharmacology, Vol. 85 (september 2019) , p. 2524-2539  

Vea también: autores con nombres similares
1 Gardarsdottir, H.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.